Wednesday, April 04, 2012

Icahn lashes Amylin board, urges sale of company | Reuters


Activist investor Carl Icahn lashed out at the board of Amylin Pharmaceuticals Inc on Wednesday, urging it to put the company up for sale and threatening a proxy fight.

Icahn, the company's third-largest shareholder with an 8.9 percent stake, criticized Amylin for failing to confirm or deny media reports that it had rejected a takeover offer from Bristol-Myers Squibb Co of $22 a share, or $3.5 billion. Bristol has also declined to comment on the reports.

Posted via email from Jack's posterous

No comments: